Webinars
Webinars
Webinars are hour-long interactive programs led by lymphoma experts who discuss the diagnosis and treatment of specific lymphoma subtypes and key research and treatment updates. Webinars feature a presentation from the featured expert, with the remainder of the time allocated to an extensive Q&A session.
Recommended for: Webinars are suggested for patients and their care partners who prefer a more interactive learning experience and who are interested in learning more about a specific lymphoma or cancer-related topic.
CAR T-Cell Therapy, Bispecific Antibodies, & Antibody-Drug Conjugates
Featuring: Sam Yamshon, MD, Weill Cornell Medicine; Justin Kline, MD, University of Chicago
Date: Tuesday, July 22, 2025
Time: 1:00-2:15PM ET
Program Overview
- Overview of Immunotherapies
- When to Consider Immunotherapies as a Treatment Option for Lymphoma
- Managing Potential Treatment Side Effects
- Looking Forward: Update on Clinical Trials for Immunotherapies
- Question and Answer Session
Register Here:
You may also register by calling or emailing our Helpline at 800-500-9976 or lymphoma@lymphoma.org.
Featuring:
Andrew Evens, MD; Chair, Scientific Advisory Board
Gina Aracena, Director of Patient Education and Support Services, Lymphoma Research Foundation
Date: Thursday, September 4, 2025
Time: 1:00-2:00PM ET
Program Overview
- What are the Phases of Drug Development?
- Responsibilities of the Food and Drug Administration (FDA)
- The Role of Clinical Trials in Treating Lymphoma and CLL/SLL
- The Lymphoma Research Foundation’s Clinical Trials Information Service
- Question and Answer Session
Register Here:
You may also register by calling or emailing our Helpline at 800-500-9976 or lymphoma@lymphoma.org.
Featuring: Philippe Armand, MD, PhD, Dana-Farber Cancer Institute; Carla Casulo, MD, University of Rochester Wilmot Cancer Center
Date: Monday, September 29, 2025
Time: 1:30 – 2:45 PM ET
Program Overview
- Overview of Follicular Lymphoma
- Active Surveillance (Watch and Wait)
- Treatment Options for Newly Diagnosed Patients
- Treatment Options for Relapsed/Refractory Patients
- Emerging Treatment Options
- Questions and Answers
Register Here:
You may also register by calling or emailing our Helpline at 800-500-9976 or lymphoma@lymphoma.org.